An Open-Label Study Evaluating the Pharmacokinetics and Safety of Diclofenac Potassium for Oral Solution for the Acute Treatment of MWA or MWoA in Pediatric Participants.

Jennifer Williams McVigeRebecca M HoganClayton M ShanahanDiane L AmendShawn M Ferger

Published in: Headache (2020)

Diclofenac potassium for OS exhibited a favorable pharmacokinetic and safety profile in 12- to 17-year-old patients with a diagnosis of episodic MWA or MWoA.

Keyphrases

liver failure
respiratory failure
drug induced
hepatitis b virus
combination therapy
aortic dissection
mechanical ventilation